{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T03:19:49Z","timestamp":1790651989556,"version":"4.1.0"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,4,5]],"date-time":"2025-04-05T00:00:00Z","timestamp":1743811200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,4,5]],"date-time":"2025-04-05T00:00:00Z","timestamp":1743811200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arthritis Res Ther"],"DOI":"10.1186\/s13075-025-03538-3","type":"journal-article","created":{"date-parts":[[2025,4,5]],"date-time":"2025-04-05T06:20:23Z","timestamp":1743834023000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Concomitant Sj\u00f6gren\u2019s disease in patients with NMOSD: impacts on neurologic disease severity and recurrence"],"prefix":"10.1186","volume":"27","author":[{"given":"Wanqing","family":"Wu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenbo","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helian","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoni","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hai","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minrui","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8108-9013","authenticated-orcid":false,"given":"Xiangjun","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,4,5]]},"reference":[{"issue":"7","key":"3538_CR1","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1056\/NEJMra1904655","volume":"387","author":"DM Wingerchuk","year":"2022","unstructured":"Wingerchuk DM, Lucchinetti CF. Neuromyelitis optica spectrum disorder. N Engl J Med. 2022;387(7):631\u20139.","journal-title":"N Engl J Med"},{"issue":"1","key":"3538_CR2","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1111\/bpa.12099","volume":"24","author":"CF Lucchinetti","year":"2014","unstructured":"Lucchinetti CF, et al. The pathology of an autoimmune astrocytopathy: lessons learned from neuromyelitis optica. Brain Pathol. 2014;24(1):83\u201397.","journal-title":"Brain Pathol"},{"issue":"9","key":"3538_CR3","doi-asserted-by":"crossref","first-page":"2721","DOI":"10.1093\/brain\/awaa227","volume":"143","author":"C Richard","year":"2020","unstructured":"Richard C, et al. Connexins in neuromyelitis optica: a link between astrocytopathy and demyelination. Brain. 2020;143(9):2721\u201332.","journal-title":"Brain"},{"issue":"6","key":"3538_CR4","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/s11926-021-01000-2","volume":"23","author":"RA Cruz","year":"2021","unstructured":"Cruz RA, et al. Neuromyelitis optica spectrum disorders (NMOSD) and connective tissue disease (CTD): an update for the rheumatologist. Curr Rheumatol Rep. 2021;23(6):33.","journal-title":"Curr Rheumatol Rep"},{"key":"3538_CR5","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1007\/s13760-019-01176-6","volume":"120","author":"T Gkaniatsou","year":"2020","unstructured":"Gkaniatsou T, et al. Frequency of autoimmune disorders and autoantibodies in European patients with neuromyelitis optica spectrum disorders. Acta Neurol Belg. 2020;120:223\u20135.","journal-title":"Acta Neurol Belg"},{"key":"3538_CR6","doi-asserted-by":"crossref","first-page":"2791","DOI":"10.1007\/s10067-020-05537-y","volume":"40","author":"F Barcelos","year":"2021","unstructured":"Barcelos F, et al. Lymphocyte subpopulations in Sj\u00f6gren\u2019s syndrome are distinct in anti-SSA-positive patients and related to disease activity. Clin Rheumatol. 2021;40:2791\u2013804.","journal-title":"Clin Rheumatol"},{"issue":"10","key":"3538_CR7","doi-asserted-by":"crossref","first-page":"1596","DOI":"10.1177\/09612033211027928","volume":"30","author":"R Villuendas","year":"2021","unstructured":"Villuendas R, et al. Usefulness of cardiac screening in patients with systemic lupus erythematosus and anti-Ro\/SSA antibodies. Lupus. 2021;30(10):1596\u2013602.","journal-title":"Lupus"},{"key":"3538_CR8","doi-asserted-by":"crossref","first-page":"1938","DOI":"10.1007\/s00415-020-10377-6","volume":"268","author":"T Akaishi","year":"2021","unstructured":"Akaishi T, et al. Impact of comorbid Sj\u00f6gren syndrome in anti-aquaporin-4 antibody-positive neuromyelitis optica spectrum disorders. J Neurol. 2021;268:1938\u201344.","journal-title":"J Neurol"},{"issue":"6","key":"3538_CR9","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1177\/1352458511431727","volume":"18","author":"R Estiasari","year":"2012","unstructured":"Estiasari R, et al. Comparison of clinical, immunological and neuroimaging features between anti-aquaporin-4 antibody-positive and antibody-negative Sj\u00f6gren\u2019s syndrome patients with central nervous system manifestations. Mult Scler J. 2012;18(6):807\u201316.","journal-title":"Mult Scler J"},{"key":"3538_CR10","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1590\/0004-282X20140097","volume":"72","author":"DC Carvalho","year":"2014","unstructured":"Carvalho DC, et al. Sj\u00f6gren syndrome and neuromyelitis optica spectrum disorder co-exist in a common autoimmune milieu. Arq Neuropsiquiatr. 2014;72:619\u201324.","journal-title":"Arq Neuropsiquiatr"},{"key":"3538_CR11","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1007\/s10072-016-2751-2","volume":"38","author":"YH Zhong","year":"2017","unstructured":"Zhong YH, et al. Comparisons of presentations and outcomes of neuromyelitis optica patients with and without Sj\u00f6gren\u2019s syndrome. Neurol Sci. 2017;38:271\u20137.","journal-title":"Neurol Sci"},{"issue":"2","key":"3538_CR12","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1212\/WNL.0000000000001729","volume":"85","author":"DM Wingerchuk","year":"2015","unstructured":"Wingerchuk DM, et al. International consensus diagnostic criteria for neuromyelitis optica spectrum disorders. Neurology. 2015;85(2):177\u201389.","journal-title":"Neurology"},{"issue":"9","key":"3538_CR13","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/S1474-4422(07)70216-8","volume":"6","author":"DM Wingerchuk","year":"2007","unstructured":"Wingerchuk DM, et al. The spectrum of neuromyelitis optica. Lancet Neurol. 2007;6(9):805\u201315.","journal-title":"Lancet Neurol"},{"issue":"1","key":"3538_CR14","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1136\/annrheumdis-2016-210571","volume":"76","author":"CH Shiboski","year":"2017","unstructured":"Shiboski CH, et al. 2016 American College of Rheumatology\/European League Against Rheumatism classification criteria for primary Sj\u00f6gren\u2019s syndrome: a consensus and data-driven methodology involving three international patient cohorts. Ann Rheum Dis. 2017;76(1):9\u201316.","journal-title":"Ann Rheum Dis"},{"issue":"4","key":"3538_CR15","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1002\/acr.21591","volume":"64","author":"SC Shiboski","year":"2012","unstructured":"Shiboski SC, et al. American College of Rheumatology classification criteria for Sj\u00f6gren\u2019s syndrome: a data-driven, expert consensus approach in the Sj\u00f6gren\u2019s International Collaborative Clinical Alliance cohort. Arthritis Care Res (Hoboken). 2012;64(4):475\u201387.","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"11","key":"3538_CR16","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1212\/WNL.33.11.1444","volume":"33","author":"JF Kurtzke","year":"1983","unstructured":"Kurtzke JF. Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology. 1983;33(11):1444\u20131444.","journal-title":"Neurology"},{"issue":"1","key":"3538_CR17","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1007\/s00415-017-8676-8","volume":"265","author":"D Conradsson","year":"2018","unstructured":"Conradsson D, et al. Changes in disability in people with multiple sclerosis: a 10-year prospective study. J Neurol. 2018;265(1):119\u201326.","journal-title":"J Neurol"},{"issue":"3","key":"3538_CR18","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1097\/WCO.0000000000000694","volume":"32","author":"K Fujihara","year":"2019","unstructured":"Fujihara K. Neuromyelitis optica spectrum disorders: still evolving and broadening. Curr Opin Neurol. 2019;32(3):385\u201394.","journal-title":"Curr Opin Neurol"},{"key":"3538_CR19","volume":"46","author":"X Ma","year":"2020","unstructured":"Ma X, et al. Risk of relapse in patients with neuromyelitis optica spectrum disorder: Recognition and preventive strategy. Mult Scler Relat Disord. 2020;46: 102522.","journal-title":"Mult Scler Relat Disord"},{"issue":"2","key":"3538_CR20","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1111\/ene.12714","volume":"23","author":"H Masuda","year":"2016","unstructured":"Masuda H, et al. Serum antinuclear antibody may be associated with less severe disease activity in neuromyelitis optica. Eur J Neurol. 2016;23(2):276\u201381.","journal-title":"Eur J Neurol"},{"issue":"2","key":"3538_CR21","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1212\/WNL.0000000000011153","volume":"96","author":"V Papp","year":"2021","unstructured":"Papp V, et al. Worldwide incidence and prevalence of neuromyelitis optica: a systematic review. Neurology. 2021;96(2):59\u201377.","journal-title":"Neurology"},{"issue":"5","key":"3538_CR22","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1097\/01.md.0000141099.53742.16","volume":"83","author":"S Delalande","year":"2004","unstructured":"Delalande S, et al. Neurologic manifestations in primary Sj\u00f6gren syndrome: a study of 82 patients. Medicine. 2004;83(5):280\u201391.","journal-title":"Medicine"},{"issue":"1","key":"3538_CR23","volume":"12","author":"Y Wu","year":"2022","unstructured":"Wu Y, et al. Incidence of neuromyelitis optica spectrum disorders in China: a large cohort study using claim data. BMJ Open. 2022;12(1): e048942.","journal-title":"BMJ Open"},{"key":"3538_CR24","volume":"58","author":"L Lin","year":"2022","unstructured":"Lin L, et al. Clinical significance of anti-SSA\/Ro antibody in Neuromyelitis optica spectrum disorders. Multiple Sclerosis Related Disord. 2022;58: 103494.","journal-title":"Multiple Sclerosis Related Disord"},{"issue":"28","key":"3538_CR25","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000001145","volume":"94","author":"L Qiao","year":"2015","unstructured":"Qiao L, et al. The clinical characteristics of primary Sjogren\u2019s syndrome with neuromyelitis optica spectrum disorder in China: a STROBE-compliant article. Medicine. 2015;94(28): e1145.","journal-title":"Medicine"},{"issue":"9","key":"3538_CR26","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1136\/jnnp.2005.080390","volume":"77","author":"I Nakashima","year":"2006","unstructured":"Nakashima I, et al. Clinical and MRI features of Japanese patients with multiple sclerosis positive for NMO-IgG. J Neurol Neurosurg Psychiatry. 2006;77(9):1073\u20135.","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"3","key":"3538_CR27","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1002\/ana.20770","volume":"59","author":"BG Weinshenker","year":"2006","unstructured":"Weinshenker BG, et al. Neuromyelitis optica IgG predicts relapse after longitudinally extensive transverse myelitis. Ann Neurol. 2006;59(3):566\u20139.","journal-title":"Ann Neurol"},{"issue":"9","key":"3538_CR28","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1001\/jamaneurol.2013.3071","volume":"70","author":"SH Kim","year":"2013","unstructured":"Kim SH, et al. A 5-year follow-up of rituximab treatment in patients with neuromyelitis optica spectrum disorder. JAMA Neurol. 2013;70(9):1110\u20137.","journal-title":"JAMA Neurol"},{"issue":"3","key":"3538_CR29","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1001\/jamaneurol.2013.668","volume":"70","author":"BC Kieseier","year":"2013","unstructured":"Kieseier BC, et al. Disease amelioration with tocilizumab in a treatment-resistant patient with neuromyelitis optica: implication for cellular immune responses. JAMA Neurol. 2013;70(3):390\u20133.","journal-title":"JAMA Neurol"},{"issue":"3","key":"3538_CR30","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.autrev.2017.01.011","volume":"16","author":"M Piga","year":"2017","unstructured":"Piga M, et al. Demyelinating syndrome in SLE encompasses different subtypes: do we need new classification criteria? Pooled results from systematic literature review and monocentric cohort analysis. Autoimmun Rev. 2017;16(3):244\u201352.","journal-title":"Autoimmun Rev"},{"key":"3538_CR31","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1007\/BF00588375","volume":"35","author":"L Pierot","year":"1993","unstructured":"Pierot L, et al. Asymptomatic cerebral involvement in Sj\u00f6gren\u2019s syndrome: MRI findings of 15 cases. Neuroradiology. 1993;35:378\u201380.","journal-title":"Neuroradiology"},{"issue":"6","key":"3538_CR32","doi-asserted-by":"crossref","first-page":"2987","DOI":"10.1007\/s00415-023-11613-5","volume":"270","author":"T Seeliger","year":"2023","unstructured":"Seeliger T, et al. Sj\u00f6gren\u2019s syndrome with and without neurological involvement. J Neurol. 2023;270(6):2987\u201396.","journal-title":"J Neurol"},{"issue":"5","key":"3538_CR33","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1136\/ard.2007.077883","volume":"67","author":"N Sofat","year":"2008","unstructured":"Sofat N, Venables PJ. Is Sj\u00f6gren myelopathy Devic disease? Ann Rheumatic Dis. 2008;67(5):730\u20131.","journal-title":"Ann Rheumatic Dis"}],"container-title":["Arthritis Research & Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13075-025-03538-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13075-025-03538-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13075-025-03538-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,5]],"date-time":"2025-04-05T06:21:43Z","timestamp":1743834103000},"score":1,"resource":{"primary":{"URL":"https:\/\/arthritis-research.biomedcentral.com\/articles\/10.1186\/s13075-025-03538-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,5]]},"references-count":33,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3538"],"URL":"https:\/\/doi.org\/10.1186\/s13075-025-03538-3","relation":{},"ISSN":["1478-6362"],"issn-type":[{"value":"1478-6362","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,5]]},"assertion":[{"value":"27 September 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 March 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 April 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was conducted in accordance with the guidelines of the Declaration of Helsinki and approved by the Ethics Committee of Huashan Hospital, Fudan University: (2023) Trial No. (529).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"78"}}